Novo Nordisk has pulled ahead in the race to bring the first oral GLP-1 for obesity to market. The company announced Friday ...

That is according to the chief executive of the American Association for the Advancement of Science (AAAS), Sudip Parikh, who ...

Meanwhile, there was more encouraging news for the UK's science base after it emerged that the country's research teams have won £500 million in research grants from the EU after being excluded from ...

Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic ...

According to the WSJ, the universal vaccine project is being pioneered by two recently appointed senior scientists in the NIH ...

GSK has highlighted approval of Nucala in COPD as one of its top 2025 priorities, adding to its established medicines for the ...

Here, we trace RWE's remarkable evolution from its handwritten roots through technological breakthroughs, methodological ...

But international agreements are notoriously difficult to enforce, and pharma companies and patient advocates who were ...

Using advanced imaging technologies as a means to enhance diagnostic accuracy was also of interest. Many HCPs pointed to the ...

Despite these benefits, biosimilar medicines remain under-recognised and underused in many markets. Real-world uptake often ...

Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo ...

According to the Elsevier 2024 Gender Equality in Research & Innovation Report, women researchers are well-represented across ...